133 related articles for article (PubMed ID: 34668391)
1. Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer's disease.
Liu L; Liu L; Lu Y; Zhang T; Zhao W
Biomark Med; 2021 Nov; 15(16):1499-1507. PubMed ID: 34668391
[No Abstract] [Full Text] [Related]
2. Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN.
Cao F; Liu Z; Sun G
Exp Gerontol; 2020 Feb; 130():110814. PubMed ID: 31857133
[TBL] [Abstract][Full Text] [Related]
3. Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.
Piscopo P; Grasso M; Puopolo M; D'Acunto E; Talarico G; Crestini A; Gasparini M; Campopiano R; Gambardella S; Castellano AE; Bruno G; Denti MA; Confaloni A
J Alzheimers Dis; 2018; 65(2):455-464. PubMed ID: 30056425
[TBL] [Abstract][Full Text] [Related]
4. MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
Yu L; Li H; Liu W; Zhang L; Tian Q; Li H; Li M
Mol Genet Genomic Med; 2021 Jan; 9(1):e1548. PubMed ID: 33220166
[TBL] [Abstract][Full Text] [Related]
5. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
Liu Q; Lei C
Exp Gerontol; 2021 Feb; 144():111187. PubMed ID: 33279668
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-511-3p regulates Aβ
Wang T; Zhao W; Liu Y; Yang D; He G; Wang Z
Exp Gerontol; 2023 Jul; 178():112195. PubMed ID: 37121335
[TBL] [Abstract][Full Text] [Related]
10. Differential Expression of miR-381-3p in Alzheimer's Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation.
Zhang M; Liu Y; Teng P; Yang Q
Neuroimmunomodulation; 2022; 29(3):211-219. PubMed ID: 34749366
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-β induced neurotoxicity.
Zhang H; Liu W; Ge H; Li K
Neurosci Lett; 2021 Jun; 756():135953. PubMed ID: 33979697
[TBL] [Abstract][Full Text] [Related]
12. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
13. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
Wang J; Chen C; Zhang Y
J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
[TBL] [Abstract][Full Text] [Related]
14. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-4722-5p and microRNA-615-3p serve as potential biomarkers for Alzheimer's disease.
Liu Y; Xu Y; Yu M
Exp Ther Med; 2022 Mar; 23(3):241. PubMed ID: 35222718
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
18. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
Dong Z; Gu H; Guo Q; Liang S; Xue J; Yao F; Liu X; Li F; Liu H; Sun L; Zhao K
Mol Neurobiol; 2021 Jul; 58(7):3084-3094. PubMed ID: 33629272
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-199a-3p Exhibits Beneficial Effects in Asymptomatic Atherosclerosis by Inhibiting Vascular Smooth Muscle Cell Proliferation and Migration.
Sun X; Zhang Y; Liu Z; Li S; Wang L
Mol Biotechnol; 2021 Jul; 63(7):595-604. PubMed ID: 33811301
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.
Kim SH; Choi KY; Park Y; McLean C; Park J; Lee JH; Lee KH; Kim BC; Huh YH; Lee KH; Song WK
Cells; 2021 Oct; 10(10):. PubMed ID: 34685681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
